aspartic acid has been researched along with Amentia in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (12.24) | 18.7374 |
1990's | 8 (16.33) | 18.2507 |
2000's | 22 (44.90) | 29.6817 |
2010's | 13 (26.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garringer, HJ; Ghetti, B; Gnezda, A; Murrell, J; Sammeta, N; Vidal, R | 1 |
Kantarci, K | 2 |
Augusciak-Duma, AM; Banasik, TJ; Bujak, MA; Opala, G; Siuda, JS; Targosz-Gajniak, MG; Wicher, MM | 1 |
Arai, H; Fujii, C; Hata, S; Higuchi, S; Igarashi, K; Ishii, R; Iwai, N; Moriya, M; Ohrui, T; Suzuki, T; Tokuda, T; Uemura, K; Waragai, M; Yoshida, M | 1 |
Dubovický, M; Kašparová, S; Kucharská, J; Liptaj, T; Lipták, B; Sumbalová, Z; Szomolányi, P; Trattnig, S; Tušková, R; Uličná, O; Vančová, O | 1 |
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL | 1 |
Kawamata, T; Ryu, B; Shimizu, M; Shimizu, T; Wakai, T; Yagi, S | 1 |
Abner, E; Caban-Holt, A; Davis, R; Gold, BT; Head, E; Jicha, G; Lin, AL; Powell, D; Robertson, W; Schmitt, FA; Wilcock, DM | 1 |
Antúnez, C; Carles, R; Fortuna, L; García Santos, JM; Gavrila, D; Jiménez Veiga, J; Navarro, C; Parrilla, G; Salmerón, D; Tormo, MJ; Torres del Río, S | 1 |
Ahrens, RJ; Caserta, MT; Hermida, AP; Ragin, A; Wise, L | 1 |
Boeve, BF; Jack, CR; Kantarci, K; Knopman, DS; Negash, S; O'Brien, PC; Petersen, RC; Przybelski, SA; Shiung, MM; Weigand, SD; Whitwell, JL | 1 |
Frölich, L; Kratzsch, T; Lais, C; Lanfermann, H; Maurer, K; Pantel, J; Pilatus, U; Rochmont, Adu M; Zanella, FE | 1 |
Bakar, M; Gumustas, O; Parlayan, E; Yulug, B | 1 |
Essig, M; Gerigk, L; Giesel, F; Hauser, T; Schuster, L | 1 |
Archer, N; Beacher, F; Daly, E; Foy, CML; Lamar, M; Lovestone, S; Morris, RG; Murphy, DGM; Murphy, KC; Poppe, M; Prasher, V; Simmons, A | 1 |
Arlt, S; Block, W; Ende, G; Frölich, L; Gür, O; Hammen, T; Jessen, F; Kornhuber, J; Kucinski, T; Lewczuk, P; Maier, W; Peters, O; Popp, J; Träber, F; Wiltfang, J | 1 |
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J | 1 |
Bacher, R; Kemmler, G; Lingg, A; Marksteiner, J; Vonbank, H; Weiss, U | 1 |
Ito, H; Kizu, O; Nishimura, T; Yamada, K | 1 |
Boeve, BF; Edland, SD; Ferman, TJ; Ivnik, RJ; Jack, CR; Kantarci, K; Knopman, DS; O'Brien, PC; Petersen, RC; Smith, GE; Tang-Wai, DF; Tangalos, EG; Weigand, SD | 1 |
Ahn, KH; Cohen, BM; Frederick, BD; Kim, MJ; Lyoo, IK; Renshaw, PF; Satlin, A; Yurgelun-Todd, DA | 1 |
Capizzano, AA; Chao, LL; Chui, HC; Du, AT; Jagust, WJ; Kramer, JH; Miller, BL; O'Neill, J; Schuff, N; Weiner, MW; Wolkowitz, OM; Yaffe, K | 1 |
Adalsteinsson, E; Pfefferbaum, A; Sullivan, EV | 1 |
Cherubini, A; Feliziani, FT; Gobbi, G; Mariani, E; Mecocci, P; Metastasio, A; Pelliccioli, GP; Rinaldi, P; Senin, U; Tarducci, R | 1 |
Abe, K; Hattori, N; Mihara, M; Sakoda, S; Sawada, T | 1 |
Birchall, D; Coulthard, E; English, P; Firbank, M; Griffiths, TD; O'Brien, J; Welch, J | 1 |
Armendariz, J; Behrens, MI; Budde, J; Cairns, NJ; Chakraverty, S; Gitcho, M; Goate, AM; Hinrichs, AL; Kauwe, JS; Levitch, D; Liscic, RM; Morris, JC; Mukherjee, O; Norton, J; Pastor, P; Shears, S; Taylor-Reinwald, L; Tenenholz Grinberg, L; Tu, PH | 1 |
Fox, NC; Garrard, P; Hodges, JR; MacManus, DG; Schott, JM; Waldman, AD | 1 |
Bosch, B; Caprile, C; Gómez-Ansón, B; Molinuevo, JL; Monte, GC; Rami, L; Sánchez-Valle, R | 1 |
Ding, M; Gong, X; Xuan, X | 1 |
Bowen, DM; Davison, AN; Neary, D; Sims, NR; Smith, CC | 1 |
Blessed, G; Perry, EK; Perry, RH; Tarbit, I; Tomlinson, BE | 1 |
Constans, JM; Fein, G; Gerson, J; MacKay, S; Meyerhoff, DJ; Norman, D; Weiner, MW | 1 |
Ross, BD; Shonk, T | 1 |
Gifford, P; Izumi, J; Mandigo, JC; Michaelis, T; Moats, RA; Ross, BD; Shonk, TK | 1 |
Block, RE; Bowen, BC; Lampman, DA; Murdoch, JB; Pattany, PM; Quencer, RM; Sanchez-Ramos, J | 1 |
Bowen, DM; Francis, PT; Holmes, C; Procter, AW; Webster, MT | 1 |
Akiguchi, I; Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Shiino, A | 1 |
Chang, L; Ernst, T; Mehringer, CM; Melchor, R | 1 |
Becerra, L; Cheng, LL; González, RG; Lackner, A; Ma, MJ; Ptak, T; Tracey, I | 1 |
Eberling, JL; Ezekiel, F; Jagust, W; Klein, G; O'Neill, J; Reed, B; Schuff, N; Soto, G; Weiner, MW | 1 |
Goto, T; Inoue, T; Matsuoka, N; Moriguchi, A; Shirakawa, K; Wang, F | 1 |
Harada, M; Miyoshi, H; Nishitani, H; Otsuka, H; Uno, M | 1 |
Alexander, GE; Chang, L; Huang, W; Krasuski, JS; Rapoport, SI; Schapiro, MB; Shetty, HU | 1 |
Chang, LJ; Hornykiewicz, O; Kish, SJ; Mirchandani, L; Shannak, K | 1 |
Bowen, DM; Francis, PT; Neary, D; Smith, CC; Snowden, JS | 1 |
Connick, JH; English, M; Hastings, MH; Stone, TW; Winn, P | 1 |
Wilde, KM | 1 |
3 review(s) available for aspartic acid and Amentia
Article | Year |
---|---|
Proton MRS in mild cognitive impairment.
Topics: Alzheimer Disease; Animals; Aspartic Acid; Biomarkers; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Diagnosis, Differential; Disease Models, Animal; Disease Progression; Energy Metabolism; Humans; Inositol; Magnetic Resonance Spectroscopy; Mice; Translational Research, Biomedical | 2013 |
Magnetic resonance spectroscopy in common dementias.
Topics: Aspartic Acid; Biomarkers; Brain; Dementia; Humans; Inositol; Magnetic Resonance Spectroscopy | 2013 |
Endogenous excitotoxic agents.
Topics: Animals; Aspartic Acid; Cell Survival; Central Nervous System; Dementia; Epilepsy; Glutamates; Glutamic Acid; Humans; Huntington Disease; Models, Neurological; Neurons; Quinolinic Acid; Quinolinic Acids | 1987 |
2 trial(s) available for aspartic acid and Amentia
Article | Year |
---|---|
Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition Disorders; Creatine; Data Collection; Dementia; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Predictive Value of Tests; Protons; Residence Characteristics; Sensitivity and Specificity; Severity of Illness Index | 2008 |
Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases, Metabolic; Creatine; Dementia; Diagnosis, Differential; Double-Blind Method; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Predictive Value of Tests; Sensitivity and Specificity | 1995 |
44 other study(ies) available for aspartic acid and Amentia
Article | Year |
---|---|
Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.
Topics: Adaptor Proteins, Signal Transducing; Animals; Aspartic Acid; Cataract; Cerebellar Ataxia; Deafness; Dementia; Female; Gene Expression; Hippocampus; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Neocortex; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Synaptophysin; tau Proteins | 2013 |
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Protons | 2013 |
Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Brain; Choline; Dementia; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Retrospective Studies; Tritium | 2014 |
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study.
Topics: Animals; Aspartic Acid; Biomarkers; Brain; Dementia; Dipeptides; Disease Models, Animal; Galactose; Inositol; Magnetic Resonance Spectroscopy; Male; Nootropic Agents; Organ Size; Phosphorus Isotopes; Protons; Rats, Wistar; Simvastatin; Spatial Learning; Spatial Memory; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Ubiquinone | 2015 |
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus | 2016 |
Reversible Cerebral Metabolism Changes Using Proton Magnetic Resonance Spectroscopy in a Patient with Intracranial Dural Arteriovenous Fistula: A Case Report.
Topics: Aged; Aspartic Acid; Central Nervous System Vascular Malformations; Coronary Angiography; Creatine; Dementia; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Proton Magnetic Resonance Spectroscopy | 2016 |
(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.
Topics: Activities of Daily Living; Adult; Analysis of Variance; Aspartic Acid; Dementia; Down Syndrome; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Neuropsychological Tests; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2016 |
Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
Topics: Aged; Aspartic Acid; Choline; Creatine; Dementia; Female; Functional Laterality; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Severity of Illness Index | 2008 |
Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
Topics: Aged; Aged, 80 and over; Aspartic Acid; Atrophy; Biomarkers; Brain; Cerebrovascular Disorders; Cognition Disorders; Cohort Studies; Creatine; Dementia; Disease Progression; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Factors | 2009 |
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Follow-Up Studies; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Parietal Lobe; Prognosis; Severity of Illness Index | 2009 |
Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.
Topics: Aged; Aspartic Acid; Brain; Cognition Disorders; Dementia; Donepezil; Female; Humans; Indans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome | 2009 |
[MR spectroscopy in dementia].
Topics: Aspartic Acid; Biomarkers; Brain; Creatinine; Dementia; Humans; Magnetic Resonance Spectroscopy; Oligopeptides; Phosphorylcholine; Protons | 2010 |
Down syndrome with and without dementia: an in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain Chemistry; Case-Control Studies; Dementia; Down Syndrome; Female; Hippocampus; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2011 |
Association of N-acetylaspartate and cerebrospinal fluid Aβ42 in dementia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Dementia; Female; Humans; Male; Middle Aged; Mitochondria; Neurons; Peptide Fragments | 2011 |
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed | 2012 |
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Cognition Disorders; Creatine; Dementia; Dementia, Vascular; Diagnosis, Differential; Female; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Pick Disease of the Brain; Retrospective Studies; Temporal Lobe | 2003 |
Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy.
Topics: Adult; Aged; Alzheimer Disease; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dementia; Diagnosis, Differential; Female; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Radiography | 2004 |
1H MR spectroscopy in common dementias.
Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Dementia; Dementia, Vascular; Diagnosis, Differential; Down-Regulation; Female; Humans; Inositol; Lewy Body Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neurodegenerative Diseases; Protons | 2004 |
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Cognition Disorders; Creatine; Dementia; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Mental Status Schedule; Protons; Temporal Lobe | 2004 |
Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.
Topics: Aged; Aspartic Acid; Atrophy; Cognition Disorders; Dementia; Female; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Parietal Lobe; Risk Factors; Temporal Lobe | 2005 |
Cortical NAA deficits in HIV infection without dementia: influence of alcoholism comorbidity.
Topics: Adult; Alcoholism; Aspartic Acid; Brain Mapping; Case-Control Studies; Cerebral Cortex; Choline; Comorbidity; Creatine; Dementia; Female; HIV Infections; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged | 2005 |
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
Topics: Aged; Amnesia; Aspartic Acid; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Functional Laterality; Humans; Inositol; Lateral Ventricles; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Nerve Fibers, Myelinated; Predictive Value of Tests; Protons | 2006 |
Magnetic resonance spectroscopic study of Alzheimer's disease and frontotemporal dementia/Pick complex.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain Mapping; Cerebral Cortex; Creatine; Dementia; Down-Regulation; Energy Metabolism; Female; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Pick Disease of the Brain | 2006 |
Proton magnetic resonance spectroscopy in frontotemporal dementia.
Topics: Aged; Aspartic Acid; Biomarkers; Cerebral Cortex; Dementia; Female; Frontal Lobe; Gliosis; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parietal Lobe; Predictive Value of Tests; Temporal Lobe | 2006 |
HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Chromosomes, Human, Pair 17; Dementia; DNA Mutational Analysis; Family Health; Female; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Inclusion Bodies; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation, Missense; Neuropsychological Tests; tau Proteins; Ubiquitin; Valine | 2006 |
Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Atrophy; Dementia; Diagnosis, Differential; Female; Frontal Lobe; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Matched-Pair Analysis; Middle Aged; Temporal Lobe | 2006 |
Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases.
Topics: Aged; Amnesia; Anomia; Aspartic Acid; Choline; Cognition Disorders; Creatine; Dementia; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Prevalence; Severity of Illness Index; Temporal Lobe | 2008 |
Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies.
Topics: Aged; Aspartic Acid; Chi-Square Distribution; Choline; Creatine; Dementia; Female; Hippocampus; Humans; Lewy Body Disease; Magnetic Resonance Spectroscopy; Male; Protons | 2008 |
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Potassium; Temporal Lobe | 1983 |
Hippocampal free amino acids in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amino Acids; Arginine; Aspartic Acid; Dementia; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Humans; Middle Aged | 1980 |
H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Diseases; Brain Ischemia; Case-Control Studies; Cerebral Ventricles; Choline; Creatine; Dementia; Dementia, Vascular; Female; Humans; Hydrogen; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurologic Examination | 1995 |
Role of increased cerebral myo-inositol in the dementia of Down syndrome.
Topics: Adolescent; Adult; Alzheimer Disease; Aspartic Acid; Brain; Child; Child, Preschool; Choline; Creatine; Dementia; Down Syndrome; Humans; Inositol; Magnetic Resonance Spectroscopy; Middle Aged | 1995 |
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism; Female; Humans; Lactates; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphocreatine; Protons | 1995 |
Relationship between beta-amyloid precursor protein, pyramidal neurones and astrocytes in human neocortex.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Antibodies, Monoclonal; Aspartic Acid; Biological Transport; Dementia; Electrophoresis, Polyacrylamide Gel; Frontal Lobe; Humans; Immunoblotting; Molecular Weight; Temporal Lobe | 1993 |
Proton magnetic resonance spectroscopy with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Creatine; Dementia; Female; Humans; Hydrocephalus, Normal Pressure; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Reference Values | 1993 |
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Dementia; Discriminant Analysis; Female; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Hydrogen; Inositol; Lactates; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Neuroglia; Neurons; Parietal Lobe; Protons; Sensitivity and Specificity; Temporal Lobe | 1997 |
Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.
Topics: Amino Acids; Animals; Aspartic Acid; Biomarkers; Brain; Cerebral Cortex; Dementia; Haplorhini; Humans; Magnetic Resonance Spectroscopy; Neurons; Organ Specificity; Pathology; Reproducibility of Results | 1997 |
Method to correlate 1H MRSI and 18FDG-PET.
Topics: Aged; Algorithms; Analysis of Variance; Aspartic Acid; Brain; Cognition Disorders; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2000 |
FK960, a novel potential anti-dementia drug, enhances high K(+)-evoked release of somatostatin from rat hippocampal slices.
Topics: Acetylcholine; Animals; Aspartic Acid; Benzamides; Dementia; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Male; Nootropic Agents; Piperazines; Potassium; Rats; Rats, Inbred F344; Serotonin; Somatostatin; Stereoisomerism | 2001 |
Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy.
Topics: Adult; Aged; Aging; Aspartic Acid; Cerebrospinal Fluid; Corpus Striatum; Dementia; Female; Frontal Lobe; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Reference Values | 2001 |
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain; Choline; Creatine; Dementia; Female; Humans; Hydrogen; Inositol; Magnetic Resonance Imaging; Male; Middle Aged; Regression Analysis | 2001 |
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Dementia; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neurons; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Serotonin | 1985 |
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Topics: Adult; Aged; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; Epilepsy; Female; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents | 1985 |
[Comments on a geriatric drug].
Topics: Aged; Asparagine; Aspartic Acid; Dementia; Drug Combinations; Female; Hematoporphyrins; Humans; Magnesium; Male; Orotic Acid; Potassium; Procaine | 1974 |